Cytek Biosciences, Inc. (CTKB) Misses Q3 EPS by 8c

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported Q3 EPS of ($0.05), $0.08 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $48 million versus the consensus estimate of $55.48 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• Gordon Haskett cuts TJX Companies rating to Accumulate
• Dingdong (DDL) Reports Q2 EPS of RMB0.90
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance